Sleep disorder, chorea, and dementia associated with IgLON5 antibodies
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received February 23, 2015
- Accepted in final form May 20, 2015
- First Published July 23, 2015.
Author Disclosures
- Mateus M. Simabukuro, MD,
- Lidia Sabater, PhD,
- Tarso Adoni, MD, PhD,
- Rubens Gisbert Cury, MD,
- Mônica Santoro Haddad, MD,
- Camila Hobi Moreira, MD,
- Luana Oliveira, MD,
- Mateus Boaventura, MD,
- Rosana Cardoso Alves, MD, PhD,
- Leticia Azevedo Soster, MD,
- Ricardo Nitrini, MD, PhD,
- Carles Gaig, MD,
- Joan Santamaria, MD,
- Josep Dalmau, MD, PhD and
- Francesc Graus, MD, PhD
- Mateus M. Simabukuro, MD,
NONE
NONE
(1) Centro de Estudos Neurologia - Prof. Antonio B.Lefevre, funding for travel to Barcelona for the The Lancet Neurology Autoimmune Disorders Conference for a poster presentation (2) World Congress of Brain, Behavior and Emotion, funding for travel to speak at the conference
NONE
NONE
NONE
NONE
NONE
NONE
(1) Private neurology practice in Samaritano Hospital
NONE
NONE
This work was supported in part by (1) National Institutes of Health grant RO1NS077851, (2) Fondo de Investigaciones Sanitarias grant PI11/01780(Dr Dalmau).
NONE
This work was supported in part by (1) Fundació la Marató TV3
NONE
NONE
NONE
NONE
NONE
NONE
- Lidia Sabater, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Tarso Adoni, MD, PhD,
(1) Teva Neuroscience; (2) Biogen Idec
NONE
(1)TEVA - Invited Speaker; 2008, 2009, 2010, 2011, 2012, 2013, 2014. (1)Biogen Idec - Invited Speaker; 2008, 2009, 2011, 2012, 2013, 2014
(1)Arquivos de Neuro-Psiquiatria, Referee, 2008-2015; (2)Clinics, Referee, 2007-2010 (3) Arquivos de Neuro-Psiquiatria, Associate Editor, 2012-2015.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Rubens Gisbert Cury, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Mônica Santoro Haddad, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Camila Hobi Moreira, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Luana Oliveira, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Mateus Boaventura, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Rosana Cardoso Alves, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Leticia Azevedo Soster, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Ricardo Nitrini, MD, PhD,
Advisory board meeting of Janssen-Cilag in 2012 Advisory meeting with Brazilian Nutricia board in 2013
NONE
Funding for travel to Alzheimer Association International Congress. Novartis 2012 and 2013
Editor - Dementia & Neuropsychologia 2007-present Editorial Board member- Alzheimer's Disease and Associated Disordes - 2004-present Editorial Board member - International Journal of Alzheimer's Disease 2011-present
NONE
NONE
NONE
NONE
Speaker in a meeting sponsored by Novartis in 2012 peaker in a meeting sponsored by Danone (Nutricia) in 2013
NONE
I work in private clinic as clinical neurologist
NONE
NONE
NONE
FAPESP (Foundation for the support of research in the S?o Paulo State, Brazil) for epidemiology study on dementia in Brazil Federico Foundation
NONE
NONE
NONE
NONE
NONE
NONE
- Carles Gaig, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Joan Santamaria, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Josep Dalmau, MD, PhD and
NONE
NONE
NONE
Neurology, Neuroimmunology and Neuroinflammation Neurology UpToDate
Patent for Ma2 autoantibody test, patent number: 6,387,639; Issued May 14th, 2002 Patent for NMDA receptor autoantibody test; US 7,972,796 B2 July 5, 2011; European 2057466 Patents filed for GABA(B) receptor autoantibody test, GABA(A) receptor autoantibody test, DPPX autoantibody test, and IgLON5 autoantibody test.
NONE
NONE
Advance Medical
NONE
NONE
NONE
Euroimmun, research support
-NIH, RO1NS077851 (previously RO1CA107192), PI, 2011-2016 -NIMH, Eureka 1RO1MH094741, Co-PI, 2011-2015 -Instituto Carlos III, (FIS, 14/00203) -Ag?ncia de Gesti? d?Ajuts Universitaris i de Recerca (AGAUR, Generalitat de Catalunya
NONE
NONE
NONE
NMDA receptor autoantibody test/Euroimmun GABA(B)R autoantibody test/Euroimmun GABA(A)R autoantibody test/Euroimmun DPPX autoantibody test/Euroimmun Iglon5 autoantibody test/Euroimmun
Patent Ma2 autoantibody test Patent NMDAR autoantibody test Patent application for the use of GABA(B) receptor, GABA (A) receptor, DPPX and IgLON5 autoantiboddy tests
NONE
NONE
NONE
- Francesc Graus, MD, PhD
NONE
NONE
NONE
member of the editorial Board of Lancet neurology since 2002
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Grant PS09/0193 Fondo Investigaciones Santitarias. Madrid. Spain. 2009
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- From the Neurology Division (M.M.S., T.A., R.G.C., M.S.H., C.H.M., L.O., M.B., R.C.A., L.A.S., R.N.), Hospital das Clínicas, São Paulo University (HC/FMUSP), Brazil; August Pi I Sunyer Biomedical Research Institute (IDIBAPS) (L.S., J.D., F.G.), Barcelona, Spain; Hospital Clínic (C.G., J.S., F.G.), University of Barcelona, Spain; Department of Neurology (J.D.), University of Pennsylvania, Philadelphia; and Catalan Institution for Research and Advanced Studies (ICREA) (J.D.), Barcelona, Spain.
- Correspondence to Dr. Simabukuro: mateus.simabukuro{at}hc.fm.usp.br
Article usage
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Jeffrey Allen and Dr. Nicholas Purcell
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Article
Clinical manifestations of the anti-IgLON5 diseaseCarles Gaig, Francesc Graus, Yarko Compta et al.Neurology, April 05, 2017 -
Article
Anti-IgLON5 DiseaseA New Bulbar-Onset Motor Neuron Mimic SyndromeJana Werner, Ilijas Jelcic, Esther Irene Schwarz et al.Neurology: Neuroimmunology & Neuroinflammation, February 02, 2021 -
Eye on Practice
Utility of sleep studies in neurologic practiceSandra L. Horowitz, Marcel Hungs et al.Neurology: Clinical Practice, February 17, 2014 -
Articles
Sleep apnea in young abstinent recreational MDMA (“ecstasy”) consumersUna D. McCann, Francis P. Sgambati, Alan R. Schwartz et al.Neurology, December 02, 2009